Owner Novartis AG

Inventors Verma, Daya; Teng, Yue (Helen); Singh, Rajinder; Thompson, Dan

Agent Davies Collison Cave

Pub. Number AU-A-2010208270

PCT Pub. Number WO2010/088336

Priority 61/148,160 29.01.09 US

Filing date 28 January 2010

Wipo publication date 5 August 2010

A61K 9/14 (2006.01) Medicinal preparations characterised by special physical form - Particulate form, e.g. powders

A61K 9/51 (2006.01) Medicinal preparations characterised by special physical form - Nanocapsules

A61K 31/355 (2006.01)

A61K 31/4184 (2006.01)

A61K 31/4188 (2006.01)

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/04 (2006.01) Preparations for testing - X-ray contrast preparations